Biophotonic and Electromagnetic Modulation of Stem Cell Behavior: Emerging Evidence for Environmental Optimization in Regenerative Medicine

Background: Stem cell therapies have improved rapidly; however, clinical outcomes remain inconsistent. Among the factors explaining this variability, the physical environment around cells during and after transplantation has received little attention. Therefore, three lines of evidence-Ultraweak Photon Emission (UPE), Photobiomodulation (PBM) and Pulsed Electromagnetic Fields (PEMF)-point to biochemical pathways by which the electromagnetic environment influences stem cell proliferation, differentiation and migration. Objective: This review collates current knowledge on how biophotonic signals and electromagnetic fields regulate stem cell behavior and whether deliberate optimization of the electromagnetic environment could serve as an additional technique in regenerative medicine. Methods: We searched PubMed, Web of Science and Scopus for the following terms: “ultraweak photon emission and stem cells,” “photobiomodulation and mesenchymal stem cells,” and “pulsed electromagnetic field and stem cell differentiation.” English-language articles published between 2004 and 2025 were examined and 58 met our inclusion criteria. Results: UPE intensity varies with stem cell differentiation status and reflects the underlying metabolic activity. PBM at red (630-660 nm) and near-infrared (800-890 nm) wavelengths promotes Mesenchymal Stem Cell (MSC) proliferation, osteogenic commitment and migration, as evidenced by over 200 studies. Low-frequency PEMF (15-50 Hz) stimulates chondrogenic and osteogenic differentiation via calcium signaling and mammalian Target of Rapamycin (mTOR)-dependent pathways. Unexposed cell populations close to activated cells respond to photonic signals, demonstrating cell-to-cell biophotonic communication. Conclusion: The present study clearly demonstrates that stem cells are responsive to their electromagnetic environment. Optimizing biophotonic and electromagnetic settings before, during and after stem cell operations is a viable (and testable) technique for boosting regeneration outcomes. Standardized clinical practices and prospective trials are necessary next steps.